Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer

Title
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer
Authors
Keywords
Crizotinib, Erlotinib, Phase I combination trial, MET inhibitor, EGFR inhibitor
Journal
Journal of Thoracic Oncology
Volume 12, Issue 1, Pages 145-151
Publisher
Elsevier BV
Online
2016-10-05
DOI
10.1016/j.jtho.2016.09.131

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started